Study critiques corporate control of trials.
Niiler
Eric
E
D001709:Biotechnology / Q000331:legislation & jurisprudence / Q000458:organization & administration* / Q000639:trends; D017326:Clinical Trials, Phase III as Topic / Q000941:ethics / Q000331:legislation & jurisprudence / Q000639:trends*; D016265:Conflict of Interest; D017277:Drug Approval / Q000458:organization & administration*; D004345:Drug Industry / Q000458:organization & administration* / Q000639:trends; D007373:Interinstitutional Relations; D011643:Publishing; D012577:Schools, Medical / Q000458:organization & administration; D014481:United States